Page 5 - PowerPoint Presentation
P. 5

Optionality to Mitigate Risk



         Competitively advantaged in the biotech industry













                                                                                                                                                    Human
                      Drug Platform                                                   Financing
                                                                                                                                                    Capital





                 • Multiple programs; one going to                          • Follow on financing can cover                           • Use of multiple consulting firms
                    IND in approximately 18 months                             up to 2 drug programs                                     accelerates drug timeframe

                 • Platform covers many disease                             • Ability to financially partner with                     • Can scale human capital as
                    categories                                                 multiple strategic companies                              needed for each drug program
   1   2   3   4   5   6   7   8   9   10